#wegovy

[ follow ]
#novo-nordisk

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Ozempic and Wegovy linked to rare vision loss

Novo Nordisk's drugs Ozempic and Wegovy linked to higher risk of vision loss.

The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?

The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.
Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Ozempic and Wegovy linked to rare vision loss

Novo Nordisk's drugs Ozempic and Wegovy linked to higher risk of vision loss.

The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?

The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.
Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.
morenovo-nordisk
#china

Novo Nordisk sells hit weight-loss drug in China-at fraction of US price

Wegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.

Novo Nordisk launches Wegovy in China with prices well below U.S.

Wegovy launches in China at lower prices than the US, but patients must bear costs individually.

Novo Nordisk sells hit weight-loss drug in China-at fraction of US price

Wegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.

Novo Nordisk launches Wegovy in China with prices well below U.S.

Wegovy launches in China at lower prices than the US, but patients must bear costs individually.
morechina
#weight-loss

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.

Weight-loss drug linked to fewer COVID deaths - Harvard Gazette

Wegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

WeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.

Long-term Wegovy study finds weight loss plateaus a little after a year

Weight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group.

Could weight-loss drugs like Ozempic cause depressionor help treat it?

GLP-1s, a drug class used for diabetes and weight loss, could potentially be effective in treating neurological conditions.
Wegovy and Ozempic, both containing semaglutide, have shown benefits beyond weight loss and heart protection.

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.

Weight-loss drug linked to fewer COVID deaths - Harvard Gazette

Wegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

WeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.

Long-term Wegovy study finds weight loss plateaus a little after a year

Weight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group.

Could weight-loss drugs like Ozempic cause depressionor help treat it?

GLP-1s, a drug class used for diabetes and weight loss, could potentially be effective in treating neurological conditions.
Wegovy and Ozempic, both containing semaglutide, have shown benefits beyond weight loss and heart protection.
moreweight-loss
#ozempic

Patients on Ozempic are developing a rare form of sudden blindness, doctors say

People on Ozempic or Wegovy may have a higher risk of sudden blindness due to a rare condition called NAION. Eye doctors in Boston have noticed an increase in cases.

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

Ozempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.

Wegovy weight loss: The science and the hype DW 10/02/2024

Wegovy and Ozempic, despite different initial purposes, have surged in popularity as weight loss solutions, enhanced by celebrity endorsements.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

From dementia to heart disease: could weight-loss jabs transform chronic conditions? podcast

Drugs originally developed for diabetes show potential for weight loss and health benefits for chronic diseases related to aging.

Unlicensed Ozempic Alternatives Are Leading to Overdoses

Gray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.

Patients on Ozempic are developing a rare form of sudden blindness, doctors say

People on Ozempic or Wegovy may have a higher risk of sudden blindness due to a rare condition called NAION. Eye doctors in Boston have noticed an increase in cases.

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

Ozempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.

Wegovy weight loss: The science and the hype DW 10/02/2024

Wegovy and Ozempic, despite different initial purposes, have surged in popularity as weight loss solutions, enhanced by celebrity endorsements.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

From dementia to heart disease: could weight-loss jabs transform chronic conditions? podcast

Drugs originally developed for diabetes show potential for weight loss and health benefits for chronic diseases related to aging.

Unlicensed Ozempic Alternatives Are Leading to Overdoses

Gray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.
moreozempic
#obesity

Wegovy reduced Covid deaths in obese patients, study finds

Wegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.

An Obesity Drug Prevents Covid Deaths, Study Suggests

Wegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.

Wegovy reduced Covid deaths in obese patients, study finds

Wegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.

An Obesity Drug Prevents Covid Deaths, Study Suggests

Wegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.
moreobesity
#semaglutide

How People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Be cautious of semaglutide overdoses; they can lead to serious health complications and hospitalization.

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works

Semaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individuals
The approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events

How People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Be cautious of semaglutide overdoses; they can lead to serious health complications and hospitalization.

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works

Semaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individuals
The approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events
moresemaglutide
#obesity-treatment

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes
moreobesity-treatment
#medicare-coverage

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes
Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans.

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes
Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans.
moremedicare-coverage

Medicare Will Start Paying for Wegovy

Medicare may cover weight-loss drug Wegovy for select members with heart disease history
Wegovy assists in weight loss and reduces cardiovascular risk by around 20%

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%
Obesity drug Wegovy is a significant advancement in weight loss medication

Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs

The North Carolina State Health Plan has decided to end coverage for weight loss medications due to rising costs.
Appetite-suppressing drugs have been effective in helping patients lose weight and may prevent heart attacks and strokes, which can lead to high hospital bills.
[ Load more ]